What is NCT05512345 (clinicaltrials.gov) for phentolamine mesylate?
NCT05512345 is a ClinicalTrials.gov record for a study involving phentolamine mesylate. The record is used to track the trial’s purpose, eligibility, interventions, outcomes, and status on ClinicalTrials.gov.
What is the study status and design for NCT05512345?
ClinicalTrials.gov entries typically include the trial phase, enrollment size, randomization/blinding, and whether the study is recruiting, active (not recruiting), completed, or terminated. To verify the exact current status and design details for NCT05512345, you would need to open the specific ClinicalTrials.gov listing and read the “Study Status” and “Study Design” sections for that identifier.
What condition is phentolamine mesylate being tested for in this trial?
Phentolamine mesylate is usually studied in clinical settings related to its pharmacologic effects (such as blocking alpha-adrenergic receptors). The exact indication for NCT05512345 depends on what the sponsor listed in the study record’s “Condition” field.
What dosing and route does the trial use?
ClinicalTrials.gov records generally specify:
- the intervention name (phentolamine mesylate),
- route of administration (e.g., oral, IV, topical—whichever the protocol uses),
- dosing schedule,
- comparator (placebo or other treatment), and
- duration of treatment and follow-up.
Those details are specific to the NCT05512345 protocol and are shown in the listing under “Interventions.”
Who is running the trial, and where does it take place?
The sponsor and locations (countries/sites) are listed in the trial record (commonly under “Sponsor/Collaborators” and “Contacts and Locations”). This can matter for access to results (some regions publish updates sooner) and for understanding trial participation.
What outcomes does NCT05512345 measure?
ClinicalTrials.gov records include primary and secondary outcome measures. These could include efficacy endpoints, pharmacodynamic measures, and safety/tolerability outcomes (side effects, vital sign changes, lab abnormalities), depending on the trial’s goals.
How can I find the NCT05512345 phentolamine mesylate page quickly?
Use the ClinicalTrials.gov link for the identifier directly:
https://clinicaltrials.gov/study/NCT05512345
Is there any related patent/exclusivity information for phentolamine mesylate?
If you’re also researching commercial or IP context (e.g., who holds rights for specific formulations or manufacturing processes), DrugPatentWatch.com can help track patent coverage by product and geography. You can search there for phentolamine mesylate and then cross-check against the trial’s sponsor/route/formulation details.
https://www.drugpatentwatch.com/
---
Sources
- https://clinicaltrials.gov/study/NCT05512345
- https://www.drugpatentwatch.com/